1

Terbitan Jabatan Farmasi 2013

If you have any queries with regards to drugs / health, feel free to contact us at :

Drug Information Service (DIS), Pharmacy Department HRPZ II

09-7452000 Ext: 2478 (Office hours)

HRPZIIDIS@gmail.com

2

SUPERVISOR:

PN FATIMAH

CHIEF EDITOR:

Pn Sudarwaty

Zaimawati Zakaria

Siti Norzulaikha

K. Heygaajivan

Ilmi Najwa Chee shu wen Wee Joo Lie

Ng Chun shian

Nor Nabilah

Nurul Hidayah

ABC of nutrition

My Bluebook

Locker 4U

KAP of insulin technique in DM patients comparing multimedia with conventional

Research Calcium Carbonate

Drug Update: Epilim Chrono

Update of Pain Management

Research PRP: Abstract

Activity: Pharmday

3

My Blue Book is the first Smartphone application which integrates the MOH

Drug Formulary (Blue Book) from www.pharmacy.gov.my in order to provide

an accurate, detail and timely references to healthcare professions.

The integrated data includes generic name, trade name, drug category, MDC

code, indication and dosage which specially design for healthcare profes-

sions in Malaysia. User can search for specific medication simply by enter-

ing their generic or trade name. It is easily obtain by searching the keyword

My Blue Book in Google Play Store and Apple Apps Store.

- PROBLEMS BEFORE INNOVATION -

AVOIDABLE

QUESTIONS

Strength Prescriber category

Dose Dosage form

Questions regarding dosage form of

medications available in the hospital

Questions regarding prescriber category

for certain medications (A,A*, A/KK)

Queries regarding dosage and indica-

tions of medications

Questions regarding strength of

medications available in the hospital

currently.

4

- BENEFITS OF INOVATION -

My Blue Book is FREE in Google Play and Apple Apps Store!

5

Group members

K.HEYGAAJIVAN A/L KERNAS (HRPZII)

GOH MAN FYE (HUSM)

JIA LIM (HTF, PERLIS)

MyPharmacistHouse innovation group

- SITUATION AFTER INNOVATION -

>8500 active users >11 400 downloads > 60 downloads/day

- USER FEEDBACK -

6

Locker 4U merupakan salah satu projek Value

Added Service (VAS), yang mula beroperasi pada

Februari 2013. Melalui projek ini, pesakit akan

diberikan loker dan kunci persendirian bagi

membolehkan mereka menuntut ubat pada bila-

bila masa. Sebanyak 40 unit loker telah disediakan

untuk pesakit dengan kos RM30 seunit.

7

Penasihat

Fatimah bt. Abdullah

Fasilitator

R.M. Khairul Anuar bin R. Ismail

Ketua Kumpulan

Rizwan bin Ramli

Ahli Kumpulan

Hanan Hayati bt. Mamat

Wan Rosidi bin Wan Yusoff

Wan Baihakimah bt. Mamat

INOVASI KUMPULAN SMARTPHARM..

8

V itamins are natural substances found in plants and animals and known as

Essential nutrients for human beings. The name vitamin is obtained from

"vital amines" as it was originally thought that these substances were all

amines. Human body uses these substances to stay healthy and support its

many functions. There are two types of vitamins: water-soluble and fat-soluble.

Fat soluble

- Include vitamins A, D, E and K

- They are soluble in fat and are ab-

sorbed by the body from the intestinal

tract

- Fat soluble vitamins should not be con-

sumed in excess as they are stored in the

body and an excess can result in side ef-

fects.

- An excess of vitamin A may result in ir-

ritability, weight loss, dry itchy skin in

children and nausea, headache, diarrhea

in adults.

Water Soluble

- Cannot be stored in the body

- Easily destroyed or washed out

during food storage and prepara-

tion

- An excess of water soluble vita-

mins should not result in any side

effects as they will disperse in the

body fluids and voided in the

urine.

Vitamins

9

Vit

amin

gen

eric

d

escr

ipto

r n

ame

C

hem

ical

nam

e(s)

(l

ist

no

t co

mp

lete

) So

lub

ility

R

eco

mm

en

ded

d

ieta

ry a

llow

ance

s (m

ale,

age

19

70

) D

efici

ency

dis

eas

e

Up

per

Inta

ke

Leve

l (U

L/d

ay)

Ove

rdo

se d

ise

ase

Fo

od

so

urc

es

Vit

amin

A

Reti

no

l, re

tin

al, a

nd

fo

ur

caro

ten

oid

s in

clu

din

g b

eta

caro

-te

ne

Fat

900

g

Nig

ht-

blin

dn

ess,

Hy-

per

kera

tosi

s, a

nd

K

era

tom

alac

ia]

3,0

00

g

Hyp

ervi

tam

ino

sis

A

Ora

nge

, rip

e ye

llow

fru

its,

leaf

y ve

geta

ble

s, c

arro

ts, p

um

pki

n,

squ

ash

, sp

inac

h, l

iver

, so

y m

ilk,

milk

Vit

amin

B1

Thia

min

e W

ate

r 1

.2 m

g B

erib

eri,

We

rnic

ke-

Ko

rsak

off

syn

dro

me

N/D

D

row

sin

ess

or

mu

scle

re

laxa

tio

n

wit

h la

rge

do

ses.

Po

rk, o

atm

eal,

bro

wn

ric

e, v

ege-

tab

les,

po

tato

es, l

iver

, egg

s

Vit

amin

B2

Rib

ofl

avin

W

ate

r 1

.3 m

g A

rib

ofl

avin

osi

s N

/D

D

airy

pro

du

cts,

ban

anas

, po

p-

corn

, gre

en b

ean

s, a

spar

agu

s

Vit

amin

B3

Nia

cin

,nia

cin

amid

e W

ate

r 1

6.0

mg

Pel

lagr

a 3

5.0

mg

Live

r d

amag

e (d

ose

s >

2g/

day

) an

d o

ther

p

rob

lem

s

Mea

t, fi

sh, e

ggs,

man

y ve

geta

-b

les,

mu

shro

om

s, t

ree

nu

ts

Vit

amin

B5

Pan

toth

enic

aci

d

Wat

er

5.0

mg

Par

esth

esia

N

/D

Dia

rrh

ea; p

oss

ibly

n

ause

a an

d h

eart

-b

urn

.

Mea

t, b

rocc

oli,

avo

cad

os

Vit

amin

B6

Pyr

ido

x-in

e,p

yrid

oxa

min

e,p

yri

do

xal

Wat

er

1.3

1.7

mg

An

emia

, per

iph

eral

n

euro

pat

hy.

1

00

mg

Imp

airm

ent

ofp

rop

rio

cep

tio

n,

ner

ve d

amag

e (d

ose

s >

10

0 m

g/d

ay)

Mea

t, v

eget

able

s, t

ree

nu

ts, b

a-n

anas

Vit

amin

B7

Bio

tin

W

ate

r 3

0.0

g

Der

mati

tis,

ente

riti

s N

/D

R

aw e

gg y

olk

, liv

er, p

ean

uts

, ce

rtai

n v

eget

able

s

Vit

amin

B9

Folic

aci

d, f

olin

ic a

cid

W

ate

r 4

00

g M

egal

ob

lasti

c an

e-m

ia a

nd

Defi

cien

cy

du

rin

g p

regn

ancy

is

asso

ciat

ed

wit

hb

irth

d

efe

cts,

su

ch

as n

eura

l tu

be

def

ect

s

1,0

00

g

May

mas

k sy

mp

-to

ms

of

vita

min

B

12d

efici

en-

cy; o

ther

eff

ect

s.

Leaf

y ve

geta

ble

s, p

asta

, bre

ad,

cere

al, l

iver

Vit

amin

B12

C

yan

oco

bal

a-m

in,h

ydro

xyco

bal

ami

n,m

eth

ylco

bal

amin

Wat

er

2.4

g

Meg

alo

bla

stic

ane-

mia

N

/D

Acn

e-lik

e r

ash

[c

ausa

lity

is n

ot

con

clu

sive

ly e

stab

-lis

hed

].

Mea

t an

d o

ther

an

imal

pro

du

cts

Vit

amin

C

Asc

orb

ic a

cid

W

ate

r 9

0.0

mg

Scu

rvy

2,0

00

mg

Vit

amin

C m

ega-

do

sage

M

any

fru

its

and

veg

etab

les,

live

r

Comparison of vitamin A, B and C

10

Drug Update :

Epilim Chrono

Indication:

i) In the treatment of generalized or partial epilepsy, particularly with the following patterns of seizures: absence, myoclonic, tonic-clonic, atonic-mixed as well as, for partial epilepsy: simple or complex seizures, secondary generalized seizures, specific syndrome (West, Lennox-Gastatut).

ii) Treatment and prevention of mania associated with bipolar disorders.

Reference: FUKKM

Composition:

Each Epilim Chrono 200 mg contains 133.2mg Sodium Valproate and 58.0mg Valproic Acid equivalent to 500mg sodium valproate.

Each Epilim Chrono 300 mg contains 199.8mg Sodium Valproate and 87.0mg Valproic Acid equivalent to 500mg sodium valproate.

*Each Epilim Chrono 500 mg contains 333mg Sodium Valproate and 145.0mg Valproic Acid equivalent to 500mg sodium valproate.

*Listed in FUKKM (Prescriber category: B)

Administration: Epilim Chrono may be given once or twice daily. The tablets should be swallowed whole and not crushed or chewed.

Combined therapy: When starting Epilim in patients already on other anticonvulsants,

these should be tapered slowly; initiation of Epilim therapy should then be gradual, with

target dose being reached after about 2 weeks. In certain cases it may be necessary to

raise the dose by 5 to 10mg/kg/day when used in combination with anticonvulsants

Contraindications

- Active liver disease

- Personal or family history of severe hepatic dysfunction, especially drug related

- Hypersensitivity to sodium valproate

- Porphyria

Fertility, Pregnancy And Lactation

Adequate counselling should be made available to all women with epilepsy of childbear-

ing potential regarding the risks associated with pregnancy because of the potential tera-

togenic risk to the foetus. If pregnancy is planned, consideration should be given to cessa-

tion of Epilim treatment, if appropriate. Excretion of Epilim in breast milk is low considera-

tion should be given to the safety profile of Epilim, specifically haematological disorders.

11

Aktiviti Jabatan

7 Oktober 2013

Jamuan Perpisahan Persaraan Pembantu Tadbir Stor Farmasi

9 Oktober 2013

Perkarangan Foyer A&E HRPZ II

Pameran QA HRPZ II (LOCKER 4U)

Jasamu dikenang :

1. Hj Razali Bin Abdullah

2. Mahani Mohamed

3. Siti Abidah Ismail

4.

12

Aktiviti Jabatan

10 Oktober 2013

Lawatan Kerja Pengarah Kanan Perkhidmatan Farmasi KKM,

Dato Eisah A.Rahman

22-24 Oktober 2013

Kompleks Kebudayaan & Kesenian Tanjung Chat, Kota Bharu

Konvensyen QA Peringkat Kebangsaan kali ke-7

13

Aktiviti Jabatan

26 Oktober 2013

KB Mall Bowling Centre

Pertandingan Bowling di Antara Kakitangan

1-2 November 2013

Perdana Beach Resort, PCB

PharmDay 2013

14

Aktiviti Jabatan

27 November 2013

Lawatan BPF Melaka ke Jabatan Farmasi Seramai 6 orang Pegawai Farmasi daripada BPF Melaka diketuai oleh TPKN (F)

28 November 2013

Tujuan : Melihat aplikasi Mini Farmasi ICU, Farmasi A&E, Farmasi ACC ,MTAC Neuro, aktiviti 5S dan penjadualan anggota.

Lawatan kerja ke HSNZ, Kuala Terengganu

15

Aktiviti Jabatan

10-11 Disember 2013

KOMPLEKS KEBUDAYAAN & KESENIAN TANJUNG CHAT, KOTA BHARU

Tujuan : Mengenengahkan projek-projek Inovasi Locker 4U dan My Blue Book kepada semua anggota kesihatan Negeri Kelantan.

Konvensyen QAP/ Inovasi JKNK

JOHAN :

LOCKER 4U

KETIGA:

MY BLUE BOOK

16

Welcoming New Staff

Izzaty bt. Abbullah, Jonathan Tan Yang Hsien, Low Hui Sin, Mohd Nazman b. Che Razak, Norfarhan Mimi bt Mohd Noor, Nor

Naimah bt Mazlan, Nur Asma bt Abdullah@Zakaria, Nurhanis bt Maliki, Nur Hidayah bt Mohd Isa, Nur Maisarah bt Abu Bakar,

Siti Fatimah bt Anuar, Siti Suzilawani bt Zahari, Tiew Wah Peng, Wong Qiao Bin

PRP Batch

November

2013

Nur Izzati Bt Abd Aziz, Saiyida Syahira Bt Mat Zaid, Nurul Idayu Kamarusulaimi, Siti Athirah Bt Mat Junoh, Muhammad Husni B

Abd Rahman, Farahanim Bt Kasim, Lim Boon Han, Rita Pauline Sanjivi A/P James, Kuilan A/L Yogeswaran, Lee Wan Nee, Aslida

Bt Safiain @ Safian, Tan Lee Khing, Wan Nor Hafizah Bt Wan Hasan@ Wan Hamzah, Basyirah Afifah Bt Ab Razak, Yong Kai

Heng, Ng Kah Quan

PRP Batch

Disember

2013

Azleen Azreen Azmi

Pegawai Farmasi U41

Graduated from M. Pharm., International Medical Uni-versity, twinning with University of Strathclyde, Glas-gow, Scotland. (2009 2012)

PRP of HRPZ II, Kota Bharu, Kelantan (20122013)

Tarikh lapor diri: 16/12/2013

Jafaredin b. Hj. Bahazim

Pembantu Rendah Am

Transferred in from Jabatan Hospital Bintulu, Sarawak (2007 2013)

Tarikh lapor diri: 1/12/2013

17

Ke

Masnor Mat Daud, Pegawai Farmasi U48

Melahirkan bayi perempuan (anak ke-2) pada 26/12/2013

Haslina Hassan, Pen Pegawai Farmasi U29

Melahirkan bayi lelaki (anak ke-4) pada 2/10/2013

Menimang

cahaya

mata

Tahniah..